Cargando…
Myt1 overexpression mediates resistance to cell cycle and DNA damage checkpoint kinase inhibitors
Cell cycle checkpoint kinases serve as important therapeutic targets for various cancers. When they are inhibited by small molecules, checkpoint abrogation can induce cell death or further sensitize cancer cells to other genotoxic therapies. Particularly aberrant Cdk1 activation at the G2/M checkpoi...
Autores principales: | Sokhi, Sargun, Lewis, Cody W., Bukhari, Amirali B., Hadfield, Joanne, Xiao, Edric J., Fung, Jeremy, Yoon, Yea Jin, Hsu, Wen-Hsin, Gamper, Armin M., Chan, Gordon K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652759/ https://www.ncbi.nlm.nih.gov/pubmed/38020882 http://dx.doi.org/10.3389/fcell.2023.1270542 |
Ejemplares similares
-
A Myt1 family transcription factor defines neuronal fate by repressing non-neuronal genes
por: Lee, Joo, et al.
Publicado: (2019) -
Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
por: Bukhari, Amirali B., et al.
Publicado: (2022) -
Editorial: Non-cell Cycle Functions of Cell Cycle Regulators
por: Liu, Song-Tao, et al.
Publicado: (2019) -
EpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer
por: Mal, Arijit, et al.
Publicado: (2021) -
MYT1 role in the microtia‐craniofacial microsomia spectrum
por: Luquetti, Daniela V., et al.
Publicado: (2020)